Belgium Pharmaceuticals & Healthcare Report Q3 2012 - New Market Research Report
BMI View: Belgium's rapidly ageing population, traditionally high per capita consumption of medicines and a well-developed healthcare system will combine to continue providing substantial commercial opportunities for pharmaceutical sector players. However, given the need for fiscal austerities in regards to public spending in the face of economic difficulties, the prospects for the placement of expensive patented medicines onto the Belgian market will remain subdued over the short term at least, as the authorities increasingly prioritise the use of cheaper generic...
View full press release